Trials / Unknown
UnknownNCT04675320
Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Centre Georges Francois Leclerc · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study concerns the creation of a biological collection (blood samples) in patients with Epithelial Ovarian Cancer in in order to describe the immune response with PARP inhibitors.
Detailed description
The aim is to assess the impact of anti-PARP on peripheral immune populations and the amount of DNA circulating; to correlate these data with tumor infiltration, with the initial clinical characteristics and with the clinical course; compare the immunogenic effect of different anti-PARPs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | blood samples | Blood sampling during PARP inhibitor therapy |
Timeline
- Start date
- 2020-07-07
- Primary completion
- 2022-11-10
- Completion
- 2024-11-10
- First posted
- 2020-12-19
- Last updated
- 2023-12-07
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04675320. Inclusion in this directory is not an endorsement.